Paulson takes new stakes in Newmont, Iveric Bio and Madrigal in Q2
Paulson & Co., the fund headed by John Paulson, added new stakes in Iveric Bio (NASDAQ:ISEE) (25K shares), Madrigal Pharmaceuticals (NASDAQ:MDGL) (350K shares), and Newmont (NYSE:NEM) (452K shares) in Q2 2023, according to its 13F filing.
The firm closed out its stake in Bally’s Corp. (NYSE:BALY). It also no longer has stakes in Shaw Communications and Yamana Gold due to the acquisitions of the two companies.
Meanwhile, it reduced its stake in Horizon Therapeutics (NASDAQ:HZNP) to 500K shares from 1.00M shares, it disclosed in the filing.